Blaustein Marc
- SEC CIK
- 0001880032
No open-market purchases or sales filed in the past year.
Current role at each company
- FNCH Finch Therapeutics Group, Inc.Chief Operating Officeras of Feb 23, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Blaustein Marc as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 25, 2022 (view filing) | Oct 21 | 4 days | Blaustein MarcChief Operating Officer | SSale | −3.64K | $1.39 | −$5.05K | −10.0%32.6K after | |
| Feb 23, 2023 (view filing)4:05 PM ET | Feb 21 | 2 days | Blaustein MarcChief Operating Officer | SSale | −4.62K | $0.38 | −$1.76K | −14.2%28.0K after |